Northland Capital on Medtronic (MDT)

Go back to Northland Capital on Medtronic (MDT)

Medtronic, Inc. (MDT) Reports In-Line Q2 EPS; Reaffirms FY Outlook

November 20, 2012 7:17 AM EST

Medtronic, Inc. (NYSE: MDT) reported Q2 EPS of $0.88, in-line with the analyst estimate of $0.88. Revenue for the quarter came in at $4.1 billion versus the consensus estimate of $4.05 billion.

Medtronic, Inc. sees FY2013 EPS of $3.62-3.70, versus the consensus of $3.66. Sees revenue growth of... More